Search

FRIDAY, Oct. 9, 2020 (HealthDay News) — For patients hospitalized with COVID-19, remdesivir is superior for shortening time to recovery compared with placebo, according to a study published online Oct. 8 in the New England Journal of Medicine. John H. Beigel, M.D., from the National Institutes of Health in Bethesda, Maryland, and colleagues conducted a...

View this Q&A below from University of Chicago Medicine experts Dr. Michael O’Connor and Dr. Thomas Spiegel as they touch on the latest on COVID-19 treatments and outcomes. Source: University of Chicago Medicine

MONDAY, March 29, 2021 (HealthDay News) — Faces masks, hand sanitizer, and disinfecting wipes are among the types of COVID-19 personal protective equipment (PPE) that Americans can deduct as a medical expense when filing taxes this year, the Internal Revenue Service says. Deductions are allowed for purchases of COVID-19 PPE for use by an individual...

In this MD Newsline exclusive interview with hematologist/oncologist Dr. Cheryl Mensah, we discuss the most common complications of sickle cell disease. We also discuss how to address concerns about sickle cell disease and the COVID-19 vaccine. MD Newsline: What are the most common complications of sickle cell disease? Dr. Cheryl Mensah: “Sickle cell disease can...

This study found that Black and Hispanic children who live in poor neighborhoods, have public insurance, and have higher rates of comorbidities like allergies were also significantly more likely to be hospitalized for COVID-19. Although COVID-19 tends to be less severe in children, hospitalization rates among children increased fivefold in the summer of 2021, possibly...

The antiparasitic drug ivermectin inhibits in-vitro replication of viruses. However, there has been conflicting information about the effectiveness of ivermectin for treating COVID-19 and preventing SARS-CoV-2 infection. COVID-19 infections require affordable, widely accessible, and efficient treatments. Ivermectin’s effectiveness in treating COVID-19 infections has yielded conflicting results in clinical trials. The drug is believed to work...

During the COVID-19 pandemic, a disparity has been noted in outcomes along racial lines. This racial disparity also exists for other conditions and has worsened during the pandemic, especially for diseases exacerbated by concurrent coronavirus infection.  This article, published in Arthritis & Rheumatology, focuses on widening disparities among patients with rheumatic conditions. At the outset,...

WEDNESDAY, Oct. 14, 2020 (HealthDay News) — Black and Mixed/Other ethnicity are independently associated with greater hospital admission risk due to COVID-19 but are not associated with in-hospital mortality risk, according to a U.K. study published online Oct. 9 in EClinicalMedicine. Rosita Zakeri, from King’s College London in the United Kingdom, and colleagues examined whether...

Rarely, some individuals may develop symptoms of alopecia areata following COVID-19 infection or vaccination, which are associated with pro-inflammatory cytokines that are also implicated in the pathogenesis of alopecia areata. Alopecia areata (AA) concerns have emerged following COVID-19 vaccination and infection. This cross-sectional analysis evaluated the relationship between COVID-19 infection or vaccination and AA. The...

THURSDAY, Oct. 22, 2020 (HealthDay News) — The number of COVID-19-related deaths may be underestimated, according to research published in the Oct. 20 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report. Lauren M. Rossen, Ph.D., from the CDC in Atlanta, and colleagues assessed trends and demographic patterns...